In the animal kingdom, proteins of the Bcl-2 family are widely recognized as regulators of mitochondrial outer membrane permeabilization (MOMP), leading to apoptotic cell death.
INTRODUCTION
Apoptosis represents one of the hallmarks of multicellularity in the animal kingdom 1 . This process shapes the body during the embryonic development, maintains tissue homeostasis and eliminates undesirable or potentially harmful cells from the organism 2 . Proteins belonging to the Bcl-2 family represent one of the main regulators of apoptosis. They control a key step in the induction of apoptosis called the mitochondrial outer membrane permeabilization (MOMP) 3 . Initially discovered in chromosomal translocations in follicular lymphomas, Bcl-2 homologs have now been found in almost all metazoans. Indeed, genetic screening of cell death mutants performed in nematodes and subsequent studies in drosophila, zebrafish and hydra uncovered a number of Bcl-2-related proteins. [4] [5] [6] [7] . These proteins contain one to four B-cell homology domains, as well as a hydrophobic C-terminus transmembrane domain 8 . Although the control of apoptosis differs substantially between roundworms, insects and mammals, seminal experiments conducted in these models reinforced the dogma that Bcl-2 family of proteins were evolutionary selected to control the survival of the cell at the level of the mitochondria.
However, a number of Bcl-2-related proteins are localized not only to the MOM but are also found at the endoplasmic reticulum (ER). Indeed, Bcl-2 and related members bind to the ER membranes and control intracellular calcium fluxes through direct interactions with the calcium channel inositol 1,4,5-trisphosphate receptor (IP3R) [9] [10] [11] . Calcium represents a key second messenger implicated in a broad range of processes including cell cycle, cell metabolism, cell migration and apoptosis, and Bcl-2 family members have also been linked to the control of some of these processes through the control of calcium fluxes 12 .
Recently we showed that two Bcl-2 homologs named Nrz and Bcl-wav were able to orchestrate the first morphogenic movements, during early zebrafish embryonic development independently from their roles in apoptosis. Nrz exerts this non-canonical function at the ER by directly regulating IP3R permeability, whereas Bcl-wav binds to VDAC channel at the MOM and enhances mitochondrial calcium uptake 11,13 14 . We demonstrated that these molecular interactions control actomyosin contractility and dynamics in the developing embryo. Thus, the assumption that Bcl-2 family proteins appeared and were selected throughout metazoan evolution as sole MOMP regulators is now challenged 15 .
Metazoans appeared during the late Precambrian period around 780 million years ago 16 .
Placozoans represent one of the most basal branching metazoans with Trichoplax adhaerens being one of the three living representatives of this phylum 17 . It possesses the simplest animal morphology and is composed of only six cell types 18, 19 . It does not undergo embryonic development but rather divides by scission. Recently, the genome of Trichoplax adhaerens was sequenced 20 .
Here we describe the identification and the molecular characterization of four Trichoplax adhaerens Bcl-2-like (trBcl-2L1 to -2L4) proteins. Phylogenetic analyses demonstrated that Trichoplax possesses two anti-apoptotic Bcl-2 homologs (trBcl-2L1 and -2L2) and two members clustering with the pro-apoptotic subgroup (trBcl-2L3 and -2L4). We demonstrated that trBcl-2L3 is a genuine Bax-like protein, whereas trBcl-2L4 is a Bak homolog. Interestingly, trBcl-2L3 is a pro-apoptotic protein capable of inducing MOMP in bax/bak-deficient baby mouse kidney (BMK) cells whereas trBcl-2L4 acts as BH3-only sensitizer repressing antiapoptotic activities of trBcl-2L1 and trBcl-2L2.
Finally, we showed that trBcl-2L1 and trBcl-2L2 possess dual subcellular localizations at the ER and the mitochondria, and demonstrate that trBcl-2L1 controls IP3R-dependent calcium fluxes. Overall, these results suggest that Bcl-2 proteins may have emerged as multifunctional cell factors capable of controlling both MOMP and calcium fluxes.
RESULTS

In silico identification and characterization of Bcl-2-like proteins
We performed extensive tBlastN screening of the genome of the Trichoplax adhaerens Grell-BS-1999 strain publically available on the NCBI. Using the full length human Bcl-2 protein as well as individual BH and TM domains as a query we identified four protein encoding sequences potentially corresponding to Bcl-2 homologs. We named them Trichoplax adhaerens Bcl-2-like proteins or trBcl-2l ( Figure 1A ). We further confirmed the expression and the sequence of the four trbcl2-like genes in Trichoplax adhaerens by performing reverse transcriptase PCR using specific primers targeting the exon #1 of each gene ( Figure S1A ).
Sequences were deposited into the NCBI databank under the following accession numbers KU500586.1, KU500587.1, KU500588.1, and KU500589.1 corresponding to the trBcl-2L1, trBcl-2L2, trBcl-2L3 and trBcl-2L4, respectively. Multiple alignments coupled with secondary structure prediction showed that all four sequences presented the typical multidomain BH organization, the TM domain located in the C-terminus end, as well as all alpha helices secondary structures ( Figure 1A , Figure S1B ). Interestingly, analysis of the primary structure of trBcl-2L3 also highlighted a unique S/T rich region between alpha helix 1 and 2. This region was predicted as a mucin-like domain which is found in secreted proteins. Of note, during the course of our survey we were not able to detect BH3-only encoding genes in the T. adhaerens genome.
In effect, trBcl-2 homologs cluster in two groups at both genomic and protein levels. For instance all four trBcl-2-like genes possess a unique BH2 splitting intron. However this intron was relatively long for trbcl2l1 and trbcl2l2 with 1991 nt and 1725 nt, respectively whereas it was significantly shorter in trbcl2l3 and trbcl2l4 with 463 nt and 280 nt, respectively. Furthermore, trBcl-2L1 and trBcl-2L2 proteins had similar molecular weights and isoelectric points (pI): 24766 and 24282 Da and pI of 8.65 and 8.85, respectively, whereas trBcl-2L3 and 6 trBcl-2L4 were slightly bigger, 27382 and 27944 Da with lower pI 6.96 and 6.45 respectively.
Finally, using local alignment matrices and neighbor joining phylogenetic tree generation, we showed that trBcl-2L1 and trBcl-2L2 were able to cluster with the anti-apoptotic subgroup of the Bcl-2 family, whereas trBcl-2L3 and trBcl-2L4 clustered with the pro-apoptotic subgroup ( Figure 1B&C ). TrBcl-2L1 and -2L2 homologs were highly divergent, whereas trBcl-2L3 and trBcl-2L4 clustered well with Bax and Bak homologs, respectively. We hereafter named these proteins trBax and trBak, respectively.
Role of trBcl-2 proteins in the control of MOMP
To gain further mechanical insight into the molecular activity of these trBcl-2-like proteins, we performed apoptosis assay in HeLa cells by analyzing the activation of Caspase 3 using a specific antibody. The transient expression of trBcl-2L1 (2.2% ± 1.3%) and trBcl-2L2 (2.4% ± 1.2%) for 24 h did not lead to a significant increase in Caspase 3 activation compared to control cells expressing the ER-targeted EGFP (6.3% ± 5.2). Conversely, the expression of trBax (89.5% ± 4.5) and trBak (88.7% ± 4.5) led a massive Caspase 3 activation ( Figure 2A&S2A ), close to that observed with the zebrafish orthologue of Bax (zBax) (87.0% ± 4.7), suggesting that these two Trichoplax proteins are genuine Bcl-2 pro-apoptotic members ( Figure 2A&S2A ).
We further confirmed these results using zebrafish embryos as a model. Indeed, during zebrafish development, embryos are resistant to apoptotic stimuli prior to the gastrulation stage which starts approximately at 6 hours post fertilization (hpf). The forced expression of Bcl-2 pro-apoptotic proteins has been shown to induce apoptosis in these embryos prior to this stage 7, 11 . We thus injected at the one cell stage in vitro transcribed mRNA encoding for each Bcl-2 homolog. Expression of trBcl-2L1 and -2L2 did increase embryo mortality. However, the expression of trBax and trBak led to embryo death, reaching almost 100% at 6 hpf ( Figure 2B ).
Interestingly, co-expression of trBcl-2L1 and -2L2 in combination with the trBax and trBak proteins led to the complete inhibition of their pro-apoptotic activity. These results suggest that trBax and trBak are pro-apoptotic Bcl-2 members, the activities of which may be antagonized by trBcl-2L1 and -2L2 proteins probably through direct interactions. To test this hypothesis, we performed fluorescence resonance energy transfer (FRET)-based interaction analyses between an EGFP donor and an Alexa568 acceptor in BMK DKO cells. Indeed, we expressed EGFP-tagged trBax and trBak in combination with Flag-tagged trBcl-2L1 and trBcl-2L2 and performed immunofluorescence using anti-Flag and secondary antibodies coupled with Alexa568 fluorophore. Interactions between trBcl-2-like proteins were estimated by measuring the dequenching of EGFP emission induced by Alexa568 photobleaching. As seen on Figure   2C , FRET efficacy between EGFPtrBax/Flag-trBcl-2L1 (5.84%±0.84%) and EGFPtrBak/Flag-trBcl-2L2 (5.45%±0.65%) was similar to control cells expressing EGFP fused to human Bax and to Flag-tagged human Bcl-2 protein (4.92%±0.78%). Interestingly, FRET efficacy between EGFPtrBak/Flag-trBcl-2L1 (11.18%±1.34%) was close to the positive control a NeonGreen-Flag-Nrh (11.20%±0.93%) protein, whereas EGFPtrBax and Flag-trBcl-2L2 interacted only weakly (1.97%±0.96%) ( Figure 2C&S2B ). We next evaluated the capacity of trBax to induce apoptosis independently of the presence of endogenous Bax and Bak by performing a series of apoptosis assays using baby mouse kidney cells knocked out for endogenous bax and bak (BMK DKO cells) ( Figure S2C ). When expressed in these cells, EGFP tagged trBax rapidly translocated to the mitochondria where it induced mitochondrial fragmentation, ∆ψ loss and Cytochrome C release ( Figures S2D-H ).
Furthermore the majority of the trBax expressing cells were Caspase 3-positive (86.8% ± 3.1%) in comparison to control cells (0.5% ± 0.45%), demonstrating that trBax is a bona fide Bax-like protein ( Figure 2D ). Of note, trBcl-2L1 (24.8% ± 3.8%) and to lesser extent trBcl-2L2 (54.9% ± 3.1%) were able to counteract the pro-apoptotic activity of trBax ( Figure 2D ). However, inhibition of trBax pro-apoptotic activity was not restricted to Trichoplax Bcl-2 members. Indeed, when human Bcl-2 homologs were expressed in combination with trBax we observed a significant decrease in the number of Caspase 3-positive cells ( Figure 2E&S2I ). This was however not the case for all human anti-apoptotic Bcl-2 proteins. For instance Mcl-1, Bfl-1, Nrh and Bcl-w inhibited trBax in a similar manner as trBcl-2L1, while Bcl-2 and Bcl-xL had no effect on its pro-apoptotic activity, suggesting an evolutionary conservation in the interaction between the hydrophobic BH3 domain-binding groove of anti-apoptotic Bcl-2 proteins and the BH3 domain of trBax.
Next, we evaluated the effect of trBak expression on BMK DKO apoptotic cell death. Although trBak was highly expressed in BMK DKO cells, it did not result in Cytochrome C release or significant Caspase 3 activation showing that the pro-apoptotic activity of trBak is dependent on the presence of endogenous Bax or Bak ( Figure 2D&S2C -E, S2G). Interestingly, trBak coexpression inhibited the anti-apoptotic activity of trBcl-2L1 and trBcl-2L2 over trBax, without increasing its pro-apoptotic potential suggesting that this protein actually acts as a BH3-only sensitizer ( Figure 2D&2F ).
Subcellular localization of trBcl-2 proteins
In vertebrates, members of the Bcl-2 family can be localized both at the level of the mitochondria and ER. In order to test whether this feature was also present in Trichoplax Bcl-2 homologs, we transiently expressed in mammalian cells, N-terminus Flag-tagged trBcl-2-like proteins in combination with ER-targeted EGFP. Under these conditions we were able to detect trBcl-2L1 and trBcl-2L2 in mitochondrial and ER membranes ( Figure 3A ). Of note cells expressing trBcl-2L2 proteins presented hyper fused perinuclear mitochondria which presented a decreased membrane potential (data not shown). In addition, intracellular trBcl-2L2 localization was more dispersed than trBcl-2L1, suggesting that this protein could be also cytosolic. These observations were confirmed by performing subcellular fractionation on BMK DKO cells followed by immunoblotting. Indeed trBcl-2L1 was found to be membrane bound whereas a fraction of trBcl-2L2 was found in the cytosol ( Figure 3B ). When we expressed trBax and trBak we detected these proteins majorly at the level of the mitochondria with minor expression in the microsomal fraction (Figures 3A&B).
We next performed experiments in in the budding yeast Saccharomyces cerevisiae. Treatment of purified yeast mitochondria with Na2CO3 showed that trBcl-2L1 is tightly inserted in the mitochondrial membrane whereas trBcl-2L2 and trBak are more loosely attached ( Figure S3 ).
Interestingly, co-expression with P168A mutant of human Bax, which is integral mitochondrial protein leads to trBcl-2L2 and trBak stabilization at the MOM. Of note expression of trBax was highly cytotoxic and did not allowed the detection of the protein.
Bax localization to MOM represents a dynamic process of translocation and retrotranslocation
which depends on internal cues most importantly the α9 hydrophobic helix containing the TM domain but also the α1 helix and a proline residue located after the BH2 domain [21] [22] [23] . It has been shown that the point mutation of this residue at position 168 into alanine actually impairs the proper translocation-retrotranslocation dynamics of human Bax (hBax) 23, 24 . Interestingly, trBax WT is a natural alanine mutant (alanine at position 212) which is constantly located at the MOM (Figures S2F&H). It possesses α1 and α9 hydrophobic helices as well as a unique S/T rich region between α helix 1 and 2, predicted as a mucin-like domain, found in secreted proteins. In order to understand how these residues regulates trBax localization at the MOM we generated two site-directed mutants: P212A and N(8)T in which we replaced the alanine residue with proline and the eight threonine residues by asparagine residues, respectively. We also generated three trBax deletion mutants, lacking the α1 (∆α1), α9 (∆α9) or both α1and α9 (∆α1∆α9) helices ( Figure S4A ). Expression of EGFP-tagged WT trBax rapidly resulted in its translocation to the mitochondria in comparison with hBax in which a significant fraction remained cytosolic suggesting that trBax does not possess the same translocationretrotranslocation dynamics as human Bax does ( Figure S4B , Figures S2F&H).
When we expressed trBax P212A and N(8)T mutants we did not detect any changes in the subcellular distribution compared to WT trBax. However mutants lacking α9 helix but not α1 had clear cytosolic localization. Of note the mitochondrial localization of trBax was tightly correlated with its capacity to induce Caspase 3 activation as mutants lacking the TM domain had reduced capacities to induce cell death in BMK DKO cells ( Figure S4C ).
The importance of the TM domain for the subcellular localization of the other trBcl-2 proteins was further demonstrated. To this end we generated mutants lacking the last hydrophobic alpha helix (∆TM) predicted in silico. When expressed in Cos-7 cells the trBcl-2L1∆TM, L2∆TM
and trBak∆TM mainly displayed a cytosolic distribution ( Figure S4D ).
TrBcl-2L1 has a dual activity at the mitochondrion and ER
Since two members of the Bcl-2 family in Trichoplax have a dual ER/mitochondria subcellular localization, we hypothesized that these proteins may control intracellular calcium fluxes at the level of the ER. We focused on trBcl-2L1 which possesses a clear ER and mitochondrial localization without proteolytic cleavage. To test the activity of trBcl-2L1 at the ER we expressed this protein in combination with the ER targeted Ca 2+ biosensor R-CEPIA1er and subject the cells to IP3-dependent calcium release using histamine. In comparison with control cells (0.60 ± 0.051) which were transfected with the empty vector, trBcl-2L1-expressing cells had a lower level of intraluminal calcium (0.37 ± 0.082) following histamine treatment, suggesting that trBcl-2L1 is able to increase the permeability of the IP3R calcium channel ( Figure 4A -C). This calcium release from the ER led to concomitant increase in cytosolic (1.58 ± 0.02) and mitochondrial matrix Ca 2+ levels (1.60 ± 0.02) compared to control cells (1.35 ± 0.04) (1.47 ± 0.034) ( Figure S5A-D) . In order to test whether trBcl-2L1 is able to bind to IP3R we performed a co-immunoprecipitation assay in HeLa cells transiently transfected with Flag-trBcl-2L1. As shown on Figure 4D trBcl-2L1 co-immunoprecipitated with endogenous IP3R type 1 supporting that the calcium regulation is indeed IP3R dependent.
We next generated two single subcellular mutants by replacing its endogenous TM domain with the TM domain of the ER-based Cytochrome B5 protein or with the TM domain of the MOMlocalized ActA protein ( Figure S5E -H). Expression of trBcl-2L1CB5 but not trBcl-2L1ActA was able to sustain higher IP3R dependent calcium release demonstrating that indeed this molecular function of trBcl-2L1 depends on its ER-localization ( Figure 4E&F) . Interestingly, when we tested the capacities of each trBcl-2L1 mutant to repress the pro-apoptotic activity of trBax we observed the opposite result ( Figure 4G ); TrBcl-2L1ActaA was able to repress trBaxinduced apoptosis, whereas trBcl-2L1CB5 had no effect.
Altogether these results suggest that at the molecular level trBcl-2 proteins possess distinct functions in the control of the MOMP or in the regulation of intracellular calcium fluxes which are predetermined by their subcellular localization ( Figure 4H ).
DISCUSSION
During the course of our research we identified and molecularly characterized four Bcl-2 homologs encoded by the genome of Trichoplax adhaerens. All four genes harbor a single conserved BH2 splitting intron, which is located specifically after the TGG codon encoding a tryptophan residue. This specific intron is not restricted to placozoans but has been found in almost all bcl2 homologous genes in multicellular animals 25 . This observation suggests that TrBax protein also possesses a serine/threonine rich sequence located between the α1 and α2 helices. In silico prediction identified this region as a mucin-like domain. Mucins are secreted proteins subjected to O-linked glycosylation at these serine/threonine residues at the level of the Golgi apparatus. Although mutation of these residues into asparagine residues did not affect trBax subcellular localization, it is tempting to speculate that in vivo trBax might function as an excreted cellular toxin. Thus it would be of interest to detect the subcellular localization of trBax and determine its glycosylation profile in Trichoplax.
Our current results strongly suggest that in Trichoplax, trBcl-2 proteins may contribute to control apoptosis through the regulation of MOMP. Indeed, analysis of the Trichoplax genome revealed the presence of key components of the mitochondrial pathway including Apaf-1, Cytochrome C as well as initiator and effector caspases 20, 26 . However, whether apoptosis occurs in Trichoplax in vivo remains unclear. Research performed on this model using nutlin-3 a cis-imidazoline analog which inhibits the interaction between Mdm2 and p53 or roscovitine a cyclin-dependent kinase inhibitor were shown to induce TUNEL-positive cells, indicating that at least in stress conditions apoptosis may operate in placozoans 27 . Placozoans are small animals that lack embryonic development and reproduce mainly vegetatively though fission or budding. They are commonly found in coastal zones in tropical and subtropical waters 28 . Thus, it is tempting to speculate that these animals may commonly be exposed to various stresses including UV radiation, or mechanical and chemical stresses, suggesting that apoptosis may play an important role in the maintenance of homeostasis.
We finally demonstrated that the anti-apoptotic Trichoplax Bcl-2 members possess double ER and mitochondrial subcellular localization, indicating that they may act at the level of the ER
MATERIALS AND METHODS
TrBcl-2 ORF cloning and expression analysis
Approximately 100 randomly picked animals of Trichoplax adhaerens "Grell" were used for total RNA isolation (for animal culture conditions, see 29 ). The animals were initially transferred into a clean glass petri dish, washed three times with 3.5% artificial seawater (ASW) and afterwards starved overnight to prevent algae contamination. The animals were transferred into a 1,5ml Eppendorf tube and the ASW was removed after short centrifugation. Animals were lysed in 500µl pre-warmed homogenization buffer (HOM-I: 100mM Tris HCl, 10mM EDTA, 100mM NaCl, 2,5mM DTT, 0,5% SDS, 0.1% DEPC in ultra pure water at pH 8.0 and 65°C).
Proteins were digested with 25µl DEPC-treated Proteinase K (10mg/ml) for 20 minutes at 65°C. Cells were disrupted by shearing with a dounce homogenizer for 20 to 30 times. The disrupted cells were then centrifuged twice at 600 g for 5min to eliminate cell nuclei and centrifuged at 7,000 g to pelled crude mitochondria. Pellet was washed two times with fresh MB buffer and centrifuged at 10,000 g. Mitochondria were resuspended in an appropriate volume of MB buffer for further analyses. The supernatant was centrifuged at 100,000 g for 1 h, and the pellet containing the microsomal fraction was resuspended in RIPA buffer (150 mM NaCl, 1%
Nonidet P-40, 0.5% Sodium deoxycholate, 0,1% SDS, 50 mM Tris-HCl (pH 7.4), containing protease inhibitors). Fifteen µg of each subcellular fraction and 50 µg of the total fraction were analyzed by western blot.
Western blot analysis and antibodies
Western blots were performed as previously described 30 . The following antibodies were used: (1/10,000) 20 min at 37°C. Cells were then washed once with medium for 20 min and then fixed with a 4% paraformaldehyde solution for 20 min followed by 3 washes with PBS.
Following cell permeabilizaion using PBS Triton X-100 0.1% (PBT) plus BSA 3%, cells were incubated with primary antibodies Flag M2 (Sigma # F3165; dilution: 1/2,500), Cytochrome C (BD Bioscience # 556433; dilution: 1/1000) or Tom20 (Santa Cruz # sc-11415; dilution: 1/500).
Goat anti-mouse or goat anti-rabbit IgG Alexa Fluor 488 (green fluorescent) or 568 (red fluorescent) were used as secondary antibodies (Molecular Probes) and used at 1/1,000 dilution for 1 h. Nuclei were visualized using Hoechst 33342 dye (Invitrogen #H3570) at 10 µg/mL.
For FRET-based interaction analyses BMK DKO cells were transfected with Flag-tagged trBcl-2L1 and L2 in combination with EGFP-tagged trBax and trBak. Twenty four hours later cells were fixed and immunostained using mouse anti-Flag M2 antibody coupled anti-mouse Alexa568 secondary antibody. FRET was measured as previously described 9 Briefly EGFP fluorescent intensities were measured before and after photobleaching Alexa568 fluophore.
FRET efficacy was calculated using the following formula (1 − ) * 100 
Zebrafish experiments
Zebrafish (crosses between AB and TU strains) were raised and maintained at 28.5°C according to standard procedures 31 . Embryos were collected after fertilization and injected at the one-cell stage with in vitro transcribed mRNA encoding trBcl-2L1 to -2L4 proteins (100 pg total mRNA/ embryo) using mMESSAGE mMACHINE SP6 Transcription Kit (Thermo Fischer).
Embryo death was monitored at regular intervals for 6 h post-fertilization.
Yeast experiments
The 4 Trichoplax cDNAs encoding proteins having a Flag tag at their N-terminal end were cloned between the BamHI/XhoI sites of the pYES2 plasmid downstream to the inducible promoter GAL1/10.
The diploid yeast strain W303 (mat a/mat α, ade1/ade1, his3/his3, leu2/leu2, trp1/trp1, ura3/ura3) was used in all the experiment. Cells were co-transformed with pYES2-TrBcl-2like plasmids and pYES3-Bax plasmids. Two Bax variants were used: BaxWT coding the fulllength untagged human protein, and BaxP168A carrying the P168>A substitution that converts Bax into a constitutively membrane-inserted and active protein 24, 32 . 
